Search Results - "Burlet, P."

Synergistic effects of multifactor interactions on the transmission of Echinococcus spp. on the Qinghai–Tibet Plateau.

Authors: Chen, Ao Li, Zhi Meng, Ru et al.

Source: PLoS Neglected Tropical Diseases. 2/19/2026, Vol. 20 Issue 2, p1-15. 15p.

Rare SMA Patients: A Comprehensive Look at Clinical Features, Genetic Profiles and Therapeutic Approaches.

Authors: Mikhalchuk, Kristina Artemieva, Svetlana Zabnenkova, Viktoria et al.

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 10, p4301. 11p.

Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study.

Authors: Pechmann, Astrid Behrens, Max Dörnbrack, Katharina et al.

Source: Orphanet Journal of Rare Diseases. 10/23/2022, Vol. 17 Issue 1, p1-10. 10p.

Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen – a multicenter observational study.

Authors: Wurster, Claudia D. Stolte, Benjamin Kessler, Tobias et al.

Source: Orphanet Journal of Rare Diseases. 9/8/2025, Vol. 20 Issue 1, p1-9. 9p.

Disease-Modifying Therapies in Spinal Muscular Atrophy: Neurodevelopmental and Behavioral Outcomes in the Treatment Era.

Authors: Okamoto K; Department of Pediatrics, Ehime Prefectural Imabari Hospital, Imabari, Ehime, Japan. kentaro206@gmail.com.

Source: Advances in therapy [Adv Ther] 2026 May 26. Date of Electronic Publication: 2026 May 26.

Publication Type: Journal Article; Review

Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE

Defining When Nusinersen Starts to Work: Time to Clinical Benefit in Patients with SMA Types 1–3 from a Real-World Cohort in China.

Authors: Wu, Ying Li, Shuang Fan, Yanbin et al.

Source: Diagnostics (2075-4418). Jun2026, Vol. 16 Issue 12, p1828. 13p.

Differences in swallowing efficacy of disease modifying treatment between infants receiving pre-symptomatic and symptomatic administration.

Authors: McGrattan, Katlyn Elizabeth Mohr, Alicia Hofelich Miles, Anna et al.

Source: Orphanet Journal of Rare Diseases. 10/21/2025, Vol. 20 Issue 1, p1-9. 9p.

Onasemnogene Abeparvovec in Early-Onset Spinal Muscular Atrophy: An Indian Experience.

Authors: Desai, Neelu Roy, Saheli Coutinho, Franzina et al.

Source: Annals of Indian Academy of Neurology. Mar/Apr2026, Vol. 29 Issue 2, p197-205. 9p.

Lymphoid Organ Architecture and Hematopoiesis Disruption in Spinal Muscular Atrophy: Therapeutic Rescue by SMN Restoration.

Authors: Guillamón, Paula Lindner, Georg Guillen, Joel et al.

Source: International Journal of Molecular Sciences. Feb2026, Vol. 27 Issue 3, p1274. 34p.

Exploring the phenotypic and genotypic spectrum of spinal muscular atrophy in Bangladeshi children.

Authors: Parvin J Khan HA Saha NC et al.

Source: BMC neurology [BMC Neurol] 2026 May 08; Vol. 26 (1). Date of Electronic Publication: 2026 May 08.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377 (Electronic) Linking ISSN: 14712377 NLM ISO Abbreviation: BMC Neurol Subsets: MEDLINE

Record of Bone Growth Marks in Phalanges of Indian Lesser Bandicoot Rat Bandicota bengalensis [Rodentia: Muridae] inhabiting Southern India.

Authors: Bansode, Sagar Kumbar, Suresh Pawar, Sandhya et al.

Source: Journal of Ecophysiology & Occupational Health. Dec2025, Vol. 25 Issue 4, p693-700. 8p.

Targeting Astrocytic Connexin 43 Mitigates Glutamate-Driven Motor Neuron Stress in Late-Onset Spinal Muscular Atrophy.

Authors: Salmanian, Schahin Schmitt, Linda-Isabell Liebig, Kai Christine et al.

Source: Cells (2073-4409). Dec2025, Vol. 14 Issue 23, p1852. 19p.

Course of joint range of motion in children with spinal muscular atrophy receiving disease-modifying treatment.

Authors: Oude Lansink, I. L. B. Gorter, J. W. van der Pol, W. L. et al.

Source: Orphanet Journal of Rare Diseases. 11/19/2025, Vol. 20 Issue 1, p1-11. 11p.

A novel intronic variant in the ASAH1 gene enhances aberrant splicing, causing spinal muscular atrophy with progressive myoclonic epilepsy.

Authors: Bai, Jinli Li, Ping Jiao, Hui et al.

Source: Italian Journal of Pediatrics. 7/8/2025, Vol. 51 Issue 1, p1-10. 10p.

Molecular precursor pathway to Co1−xNixNb2O6 for photocatalytic dye degradation: Optical and charge transport studies.

Authors: Lozančić, Ana Vrankić, Martina Razum, Marta et al.

Source: Journal of the American Ceramic Society; Jul2025, Vol. 108 Issue 7, p1-24, 24p

Comprehensive copy number analysis of spinal muscular atrophy among the Iranian population.

Authors: Khanbazi, Ali Beheshtian, Maryam Azad, Maryam et al.

Source: Scientific Reports. 12/2/2024, Vol. 14 Issue 1, p1-11. 11p.

SMN2 gene copy number affects the incidence and prognosis of motor neuron diseases in Japan.

Authors: Ishihara, Tomohiko Koyama, Akihide Atsuta, Naoki et al.

Source: BMC Medical Genomics. 11/6/2024, Vol. 17 Issue 1, p1-7. 7p.

Harnessing natural history collections to detect trends in body‐size change as a response to warming: A critique and review of best practices.

Authors: Theriot, Miranda K. Lanier, Hayley C. Olson, Link E.

Source: Methods in Ecology & Evolution. Feb2023, Vol. 14 Issue 2, p306-318. 13p.

A rapid and easy-to-use spinal muscular atrophy screening tool based on primers with high specificity and amplification efficiency for SMN1 combined with single-stranded tag hybridization assay.

Authors: Hirano, Masaki Sahashi, Kentaro Ichikawa, Yuki et al.

Source: PLoS ONE. 8/1/2024, Vol. 19 Issue 8, p1-11. 11p.

Longitudinal Transcriptomic Analysis Reveals Systemic Effects of Risdiplam in Adults with Spinal Muscular Atrophy.

Authors: Liguori, Maria Consiglio, Arianna D'Errico, Eustachio et al.

Source: Brain Sciences (2076-3425). Jun2026, Vol. 16 Issue 6, p643. 14p.